Home › Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis clinical trials recruiting in the U.S.

71 studies for Amyotrophic Lateral Sclerosis are recruiting participants at sites across the United States.

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a nerve disease that weakens muscles and gets worse over time. Learn how to manage symptoms.

Cities with the most studies

• Boston, MA19 studies
• Jacksonville, FL12 studies
• Philadelphia, PA12 studies
• Baltimore, MD11 studies
• San Diego, CA9 studies
• Chicago, IL9 studies
• San Francisco, CA8 studies
• New York City, NY8 studies
• St. Louis, MO8 studies
• Atlanta, GA7 studies
• Phoenix, AZ7 studies
• Houston, TX7 studies
• Miami, FL6 studies
• Washington, DC6 studies
• Minneapolis, MN6 studies
• Durham, NC6 studies
• Seattle, WA6 studies
• Dallas, TX5 studies
• Ann Arbor, MI5 studies
• Mountain View, CA5 studies
• Davie, FL4 studies
• Birmingham, AL4 studies
• Los Angeles, CA4 studies
• State College, PA3 studies
• Scottsdale, AZ3 studies
• Columbus, OH3 studies
• Sacramento, CA3 studies
• Pittsburgh, PA3 studies
• Harrisburg, PA3 studies
• Tampa, FL3 studies
• Detroit, MI3 studies
• Richmond, VA3 studies
• Winston-Salem, NC3 studies
• Portland, OR3 studies
• Aurora, CO3 studies
• Gainesville, FL3 studies

By state

• Alabama4 studies
• Arizona11 studies
• California22 studies
• Colorado4 studies
• Connecticut3 studies
• District of Columbia3 studies
• Florida27 studies
• Georgia7 studies
• Illinois10 studies
• Kansas4 studies
• Maryland14 studies
• Massachusetts23 studies
• Michigan7 studies
• Minnesota8 studies
• Missouri10 studies
• Nebraska4 studies
• New Hampshire3 studies
• New York9 studies
• North Carolina8 studies
• Ohio5 studies
• Oregon3 studies
• Pennsylvania17 studies
• Tennessee4 studies
• Texas13 studies
• Utah4 studies
• Virginia5 studies
• Washington6 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.